サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1448009

飼料用抗生物質市場-2023年～2030年

Feed Antibiotics Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 181 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
飼料用抗生物質市場-2023年～2030年
出版日: 2024年03月08日
発行: DataM Intelligence
ページ情報: 英文 181 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

世界の飼料用抗生物質市場は、2022年に28億米ドルに達し、2023年から2030年の予測期間中にCAGR 4.3％で成長し、2030年には392万米ドルに達すると予測されています。

世界人口の増加と多くの地域における所得水準の上昇が、肉と乳製品の消費量増加につながっています。FAOによれば、世界の1人当たり食肉消費量は、2030年までに小売重量換算で35.4kgとなり、年間0.3%増加すると予想されます。その結果、家畜の成長と健康を促進するための抗生物質を含む動物用飼料の需要が増加しています。

飼料用抗生物質は、家畜の成長率を高め、畜産における飼料効率を改善するために一般的に使用されています。より速い成長と効率的な栄養利用を促進することで、農家は食肉と畜産物に対する世界の需要の増加に、より効果的に応えることができます。この慣行は、集約的農業システムにおいて生産性を最大化することを目的としていました。従って、飼料用抗生物質を使用することの利点に関する意識の高まりは、市場成長を後押しする重要な動向として作用します。

テトラサイクリン系抗生物質は、家畜の成長を促進し、病気を予防するために広く使用されているため、世界の飼料用抗生物質市場で重要な役割を果たしており、3分の1のシェアを占めています。同時に、アジア太平洋地域も同様に3分の1のシェアを占めており、これは主に食肉と乳製品の需要増が要因となっています。China Briefingによると、一人当たりの平均消費量が5,300万トン以上の豚肉と1,000万トン以上の牛肉・子牛肉である中国は、2022年には世界最大の食肉消費国のひとつとなった。

市場力学

動物由来の食品に対する需要の高まり

世界人口の増加と所得の上昇に伴い、肉、乳製品、卵に対する需要が高まっています。FAOによると、世界の動物性タンパク質の消費量は2018年から2030年の間に14%増加すると予想されています。2030年までに、羊、牛、豚、鶏の肉から得られるタンパク質は、それぞれ17.8％、5.9％、13.1％、15.7％増加すると予想されています。これらの家畜を健康に保ち、成長を促進するために、多くの農家は歴史的に抗生物質を飼料添加物として使用しており、これが需要の原動力となっています。

畜産における抗生物質は、成長の促進、病気の予防、治療の促進など多面的な役割を果たしています。工業的農業の混雑したストレスの多い環境は、動物間で病気がすぐに蔓延する環境を作り出しています。抗生物質はこうした病気の予防に役立ち、家畜の死亡率を低下させ、動物由来の食品の安定供給を保証します。農家は、食用動物の飼育に必要な時間と資源を削減できるため、この効率性から利益を得ています。

動物用医薬品への投資の増加

政府や民間投資家は畜産セクターの重要性をますます認識し、家畜生産施設の近代化、動物衛生管理の強化などに投資しています。2020年2月、Elanco Animal Health IncorporatedはMerck Animal Healthとの間で、Vecoxanの全世界における権利を5,500万米ドルで譲渡することで合意したと発表しました。Vecoxanは子牛と子羊のコクシジウム症の予防と治療に使用されます。このような投資は、飼料用抗生物質市場の成長を促進します。

抗生物質は病気の予防と管理のために動物飼料に欠かせないです。健康な家畜は成長が早いだけでなく、生産効率も高いです。抗生物質は、人口密度の高い畜産施設における疾病の発生を最小限に抑え、全体的な健康状態の改善と生産性の向上をもたらすという重要な役割を担っています。それゆえ、動物福祉や家畜の抗生物質使用に対する消費者の意識の高まりとともに、責任ある抗生物質使用で飼育された家畜からの製品に対する需要が高まっています。

抗生物質に対する耐性の高まり

畜産における抗生物質の使用を含め、抗生物質の過剰使用や誤用は、抗生物質耐性菌の発生につながっています。これらの耐性菌は動物に感染し、食物連鎖や環境汚染を通じてヒトに移行する可能性があり、公衆衛生上の重大なリスクとなっています。米国食肉協会は、抗生物質治療を受けた動物の肉を食べると、ヒトの抗菌剤耐性（特定の抗生物質に対する耐性）が生じると主張しています。

世界中の規制機関は、抗生物質耐性とその人体への影響についてますます懸念を強めています。その結果、多くの国が畜産における抗生物質の使用について、より厳しい規制を導入しています。例えば、欧州連合（EU）は2022年1月28日、畜産動物に抗生物質を定期的に与えることを禁止する新法を施行しました。このような規制は、使用できる抗生物質の種類を制限することが多く、畜産における抗生物質市場の成長を抑制しています。

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 動物由来食品に対する需要の高まり
      • 動物医療への投資の増加
    • 抑制要因
      • 抗生物質に対する耐性の高まり
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 タイプ別

  • テトラサイクリン系
  • ペニシリン系
  • スルホンアミド系
  • マクロライド系
  • アミノグリコシド系
  • セファロスポリン
  • その他

第8章 動物別

  • 反芻動物
  • 家禽
  • 豚
  • 水産養殖
  • 馬
  • ペット
  • その他

第9章 送達方法

  • プレミックス
  • 経口粉末剤
  • 内服液
  • 注射剤
  • その他

第10章 エンドユーザー別

  • 動物病院
  • 在宅医療
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Merck & Co., Inc.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 最近の動向
  • Zoetis Services LLC.
  • Virbac.
  • Phibro Animal Health Corporation
  • Vetoquinol
  • Ceva
  • Kyoritsuseiyaku Corporation
  • Inovet
  • MEGAMIX
  • Dechra Pharmaceuticals PLC LIST NOT EXHAUSTIVE

第14章 付録

目次
Product Code: AG8033

Overview

Global Feed Antibiotics Market reached US$ 2.80 billion in 2022 and is expected to reach US$ 3.92 million by 2030, growing with a CAGR of 4.3% during the forecast period 2023-2030.

Growing global populations and increasing income levels in many regions were leading to higher meat and dairy consumption. According to FAO, worldwide per capita meat consumption is expected to rise by 0.3% pa to 35.4 kg in retail weight equivalent by 2030. As a result, there is a greater demand for animal feed, including antibiotics to promote livestock growth and health.

Feed antibiotics were commonly employed to boost livestock growth rates and improve feed efficiency in animal farming. By promoting faster growth and efficient nutrient utilization, farmers could meet the increasing global demand for meat and animal products more effectively. This practice aimed to maximize productivity within intensive farming systems. Hence, rising awareness about the benefits of using feed antibiotics acts as a key trend for boosting market growth.

Tetracyclines play a crucial role in the global feed antibiotics market, constituting a significant one-third share due to their widespread use for promoting livestock growth and preventing diseases. At the same time, the Asia-Pacific region holds an equally substantial one-third share, mainly driven by the increasing demand for meat and dairy products. According to China Briefing, with an average per capita consumption of over 53 million tons of pork and 10 million tons of beef and veal, China was among the world's largest meat consumers in 2022.

Dynamics

Rising Demand for Animal-derived Food Products

There is a rising demand for meat, dairy, and eggs, as global populations grow and incomes rise. According to FAO, the consumption of animal proteins worldwide is anticipated to increase by 14% between 2018 and 2030. By 2030, it is anticipated that the protein available from meat from sheep, beef, pork, and poultry will increase by 17.8%, 5.9%, 13.1%, and 15.7%, respectively. To keep these animals healthy and promote growth, many farmers have historically used antibiotics as feed additives which drives its demand.

Antibiotics in animal agriculture serve a multifaceted role, promoting growth, preventing diseases, and facilitating treatment. The crowded and stressful conditions of industrial farming create an environment where diseases can quickly spread among animals. Antibiotics help prevent these diseases and reduce livestock mortality rates, ensuring a stable supply of animal-derived food products. Farmers benefit from this efficiency as it reduces the time and resources needed to raise animals for food.

Increasing Investment in Animal Health Expenditure

Governments and private investors are increasingly recognizing the importance of the livestock sector and are investing in modernizing livestock production facilities enhancing animal health management etc. In February 2020, Elanco Animal Health Incorporated announced an agreement with Merck Animal Health to transfer worldwide rights for the Vecoxan for USD 55 million in an all-cash arrangement. Vecoxan is used for the prevention and treatment of coccidiosis in calves and lambs. These types of investments in turn drive the feed antibiotics market growth

Antibiotics are crucial in animal feed for preventing and managing diseases. Healthy animals not only grow faster but also produce more efficiently, which is essential to meet the growing demand for animal products. Antibiotics play a vital role in minimizing disease outbreaks in densely populated livestock facilities, resulting in improved overall health and higher productivity levels. Hence with the growing consumer awareness of animal welfare, and antibiotic use in livestock there is a growing demand for products from animals raised with responsible antibiotic use.

Growing Resistance to Antibiotics

Overuse and misuse of antibiotics, including their use in animal agriculture, have led to the development of antibiotic-resistant bacteria. These resistant pathogens can infect animals and have the potential to transfer to humans through the food chain or environmental contamination, creating a significant public health risk. The American Meat Institute claims that eating meat from an animal that has received antibiotic treatment results in human antimicrobial resistance (resistance to certain antibiotics).

Regulatory bodies worldwide are increasingly concerned about antibiotic resistance and its impact on human health. Consequently, many countries have introduced stricter regulations governing antibiotic use in livestock farming. For instance, on January 28, 2022, the European Union implemented a new law prohibiting the routine feeding of antibiotics to farmed animals. Such regulations often restrict the types of antibiotics that can be employed, thereby constraining the growth of the antibiotic market in animal agriculture.

Segment Analysis

The global feed antibiotics market is segmented based on type, animal, mode of delivery, end-user and region.

Rising Demand Tetracyclines for Effectiveness against Various Bacteria

Tetracyclines, a class of antibiotics known for their wide-ranging effectiveness against various bacteria, play a crucial role in preventing and treating bacterial infections in animals. They excel in managing respiratory, gastrointestinal, and skin infections in animals. Regulatory agencies, including the FDA, have approved numerous tetracycline antibiotics for use in animal agriculture, underscoring their safety and suitability for this purpose. This regulatory approval instills confidence in their safety and efficacy.

Tetracyclines have a long history of successful use in veterinary medicine. Their effectiveness in controlling and preventing. Their versatile administration methods, including through feed, water, or injections, provide farmers with the flexibility to cater to the specific needs of animals and the diseases they face, making them a convenient and trusted option.

Source: DataM Intelligence Analysis (2023)

Geographical Penetration

Asia-Pcific's Growing Feed Industry

The region has embraced modern and intensive farming practices to maximize animal production efficiency. According to a study published in February 2020 by Dongguan University of Technology, Dongguan, China, in-feed antibiotic use altered behaviors of Oxytetracycline, sulfamerazine, and ciprofloxacin, as well as related antibiotic resistance genes during the composting of swine manure.

Asia-Pacific has experienced significant population growth, urbanization, and rising incomes. This has led to increased demand for animal-based protein products, such as meat, milk, and eggs. The Department of Animal Husbandry and Dairying reports that India is the world's top producer of milk. Milk production increased by 5.81% annually between 2019-2020 and 2020-21, reaching 198.44 million tonnes and 209.96 million tonnes, respectively. This rising demand for animal-derived products needs large amounts of feed antibiotics.

Key players in the feed and agriculture sectors have established a strong presence in the Asia Pacific, boosting market growth. The key players of feed antibiotics present in Asia-Pacific are Bayer Health Care AG, Virbac Animal Health, Merck Animal Health, Elanco Animal Health, etc. These companies are investing in R&D infrastructure and continuously introducing various feed additives including feed yeast. Hence, the presence of major companies acts as a key trend for the feed yeast market growth in that region.

Source: DataM Intelligence Analysis (2023)

Competitive Landscape

The major global players include Merck & Co., Inc, Zoetis Services LLC, Virbac, Phibro Animal Health Corporation, Vetoquinol, Ceva, Kyoritsuseiyaku Corporation, Inovet, MEGAMIX and Dechra Pharmaceuticals PLC.

COVID-19 Impact Analysis

COVID Impact

The pandemic disrupted global supply chains, affecting the production and distribution of feed antibiotics. This led to shortages and delays in the availability of feed antibiotics in some regions, impacting farmers' ability to maintain animal health. COVID-19 heightened consumer awareness of food safety and hygiene. This led to increased demand for products from animals raised with responsible antibiotic use or raised without antibiotics. As a result, some farmers and producers shifted towards antibiotic-free or reduced-antibiotic practices.

Concerns about antibiotic resistance have led to increased regulatory scrutiny of antibiotic use in animal agriculture. Some regions implemented stricter regulations during the pandemic, further influencing antibiotic use practices in livestock. The economic challenges brought by the pandemic, including reduced demand for certain animal products and increased production costs, made farmers more conscious of their expenses. This prompted some to reevaluate their antibiotic use and explore cost-effective alternatives.

Russia- Ukraine War Impact

Ukraine is a significant producer of agricultural commodities, including grains and animal feed ingredients. The conflict has disrupted the agricultural supply chain in the region, potentially affecting the availability and prices of feed ingredients used in animal agriculture, including those related to feed antibiotics. The conflict disrupted international trade routes and agreements, affecting the export and import of animal products and feed ingredients.

The war has led to economic instability in Ukraine and neighboring regions. Economic uncertainties affect consumer demand for animal products, which in turn can influence the production practices and antibiotic use in animal agriculture. As a response to supply chain disruptions caused by the conflict, some regions or countries may seek to diversify their sources of feed ingredients and animal products. This diversification can impact the distribution and use of feed antibiotics.

By Type

  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
  • Cephalosporins
  • Others

By Animal

  • Ruminants
  • Poultry
  • Swine
  • Aquaculture
  • Horses
  • Pets
  • Others

By Mode of Delivery

  • Premixes
  • Oral Powder
  • Oral Solution
  • Injection
  • Others

By End-User

  • Veterinary Hospitals
  • Homecare
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In July 2022, Virbac, dedicated to animal health, introduced TENOTRYL (enrofloxacin) injectable solution in the United States and expanded its product line to offer veterinarians and their clients, cattle and swine producers, a strong bench of new alternatives to enhance the health of livestock and, ultimately, their profitability.
  • In November 2021, Kemin, a manufacturer of ingredients for several industries, including human/animal health and nutrition, pet food, aquaculture etc. introduced a new product in Europe called TOXFIN CARE. This product was designed to protect animal organs and tissue from potential mycotoxin harm to prevent performance and productivity loss.
  • In July 2020, Trianni and Zoetis, an animal health company, announced an agreement, to create a transgenic antibody discovery platform for use in animal health.

Why Purchase the Report?

  • To visualize the global feed antibiotics market segmentation based on type, animal, mode of delivery, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Feed Antibiotics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global feed antibiotics market report would provide approximately 77 tables, 69 figures and 181 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Type
  • 3.2.Snippet by Animal
  • 3.3.Snippet by Mode of Delivery
  • 3.4.Snippet by End-user
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Rising Demand for Animal-derived Food Products
      • 4.1.1.2.Increasing Investment in Animal Health Expenditure
    • 4.1.2.Restraints
      • 4.1.2.1.Growing Resistance to Antibiotics
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Type

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2.Market Attractiveness Index, By Type
  • 7.2.Tetracyclines*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Penicillins
  • 7.4.Sulfonamides
  • 7.5.Macrolides
  • 7.6.Aminoglycosides
  • 7.7.Cephalosporins
  • 7.8.Others

8.By Animal

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 8.1.2.Market Attractiveness Index, By Animal
  • 8.2.Ruminants*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Poultry
  • 8.4.Swine
  • 8.5. Aquaculture
  • 8.6.Horses
  • 8.7.Pets
  • 8.8.Others

9.By Mode of Delivery

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 9.1.2.Market Attractiveness Index, By Mode of Delivery
  • 9.2.Premixes*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Oral Powder
  • 9.4.Oral Solution
  • 9.5.Injection
  • 9.6.Others

10.By End-User

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2.Market Attractiveness Index, By End-User
  • 10.2.Veterinary Hospitals*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Homecare
  • 10.4.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics
    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1.U.S.
      • 11.2.7.2.Canada
      • 11.2.7.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics
    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1.Germany
      • 11.3.7.2.UK
      • 11.3.7.3.France
      • 11.3.7.4.Italy
      • 11.3.7.5.Russia
      • 11.3.7.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics
    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1.Brazil
      • 11.4.7.2.Argentina
      • 11.4.7.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.Merck & Co., Inc.*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Recent Developments
  • 13.2.Zoetis Services LLC.
  • 13.3.Virbac.
  • 13.4.Phibro Animal Health Corporation
  • 13.5.Vetoquinol
  • 13.6.Ceva
  • 13.7.Kyoritsuseiyaku Corporation
  • 13.8.Inovet
  • 13.9.MEGAMIX
  • 13.10.Dechra Pharmaceuticals PLC LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us